经尿道等离子体双极电切术治疗前列腺增生

Transurethral plasmakinetic vaporization of prostate for treatment of BPH

目的探讨经尿道等离子体双极电切治疗前列腺增生(BPH)的安全性与有效性。方法用经尿道等离子体双极电切法行前列腺切除术(PKVP)81例。结果81例术中出血少,无前列腺电切综合征(TURS)和前列腺包膜穿孔发生。术后随访1-6个月,最大尿流率(Qmax)由术前的(6．2±4．1)ml／S上升至术后的(21．2±4．6)ml／S;国际前列腺症状评分(IPSS)由术前的(25．6±4.8)分下降至术后的(6．8±2．6)分;生活质量评分(QOL)由术前的(5．1±0．5)分降低至术后的(1．8±0．5)分;残余尿由术前的(67±70)ml减少至术后的(15±20)ml。结论经尿道等离子体双极电切治疗前列腺增生疗效确切,安全性好,并发症少。

Objective To discuss the efficacy and safety.of transurethral plasmakinetic vaporization of prostate（PKVP）. Methods Eighty one aged BPH patients were treated by PKVP. Results Less blood loss and no transurethral resection syndrome or rupture of the surgical capsule of prostate occurred, All patients followed up for 1-6 months postoperatively, the peak flow rate increased from （6.2~4.1）to（21.2~4.6）ml/s; IPSS decreased from 25.6~4.8 to 6.8~2.6; QOL decreased from 5.1 ~0.5 to 1.8~0.5. Residual urine volume decreased from （67.0~70.0） to （15.0~20.0）ml. Conclusion PKVP possesses the advantages of high safety,less complications and improving the excision rate of the prostate gland.